 an elevation in the HDL level was independently
associated with a 14% reduction in stroke risk.89
The beneﬁt of statin medications for stroke risk reduction
is most likely due to their pleiotropic effects, and these effects are being recognized in the periprocedural period for
patients undergoing CEA and CAS. A study from the
Johns Hopkins Hospital was the ﬁrst to investigate the
impact of statins on CEA outcomes. In a